Skip to main content
. 2017 Nov 16;15(1):1097–1102. doi: 10.3892/ol.2017.7432

Figure 1.

Figure 1.

Cisplatin-resistant MG63 cells demonstrate a higher clonogenic ability and proliferation, compared with non-resistant cells. (A) A clonogenic assay 14 days post-treatment and (B) an MTT proliferation assay were performed with MG63 and MG63-DDP cells. *P<0.05 and **P<0.01 vs. MG63. miR, microRNA; DDP, cisplatin.